PARIS--(BUSINESS WIRE)--TheraVectys, a biotechnology company that designs and develops lentiviral vector-based vaccines and immunotherapies against infectious agents and cancers, announces that the ...

Inspire, the world's largest online community for patients and caregivers, today announced the launch of a new online community in partnership with HPV Cancers Alliance. The community creates a ...

Investigators sought to increase HPV vaccination rates in children by age 13 years through the use of a multicomponent strategy in pediatric primary care practices.

Less than half of patients who were positive for high-risk human papillomavirus (HPV) with negative cytologic findings were retested during the guideline-recommended time frame, a cohort study showed.

The findings of a new study add to growing evidence that cotesting may offer limited clinical value despite its common use in ...

February 17, 2010 – It is well established that patients with squamous cell carcinoma of the oropharynx that tests positive for human papillomavirus (HPV) have a more favorable outcome and are more ...

Human papillomavirus (HPV) vaccination stimulates robust and sustained immune responses in girls and young women with chronic kidney disease (CKD) and those on dialysis, but less optimal responses to ...

HPV-linked oral cancers are rising sharply. Often silent in early stages, these cancers are increasingly being detected by ...

Usually, pap smears are performed at a clinic by a doctor or healthcare provider, but with the new kits, patients will have ...

Please provide your email address to receive an email when new articles are posted on . Mailing HPV self-sampling kits to women could be cost saving for health care institutions. Data showed mailing ...

What is the best way to follow a thin-prep Pap smear when the results indicate no intraepithelial lesion or malignancy, but the patient is at high risk for human papillomavirus (HPV)? Should I do ...